AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15726575
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin type A (BTXA) injection with low-frequency electrical nerve stimulation (NS) at 4 Hz
Trial: 15726575
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin type A (BTXA) injection with high-frequency electrical nerve stimulation (NS) at 25 Hz
Trial: 15726575
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin type A (BTXA) injection without electrical nerve stimulation (NS)
Trial: 11927114
Drug: Full dose
RxNorm normalized name: BayRHo-D Full Dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full dose of Yuzpe regimen
Trial: 11927114
Drug: Half dose
RxNorm normalized name: propranolol hydrochloride Extended Release Oral Capsule [Half-Betadur CR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Half dose of Yuzpe regimen
Trial: 11927114
Drug: Yuzpe regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yuzpe regimen (both doses)
Trial: 9862249
Drug: Hydrocortisone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone (50 mg intravenous bolus)
Trial: 2651178
Drug: Controlled release
RxNorm normalized name: EpiCeram Controlled Release Skin Barrier Emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled release salbutamol tablets (8 mg twice daily)
Trial: 2651178
Drug: Sustained release
RxNorm normalized name: Sustained Release Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained release theophylline preparation (400-800 mg given once each night)
Trial: 154872
Drug: oral antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oral antibiotic + topical placebo lotion
Trial: 154872
Drug: oral antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oral antibiotic + topical ethyl lactate lotion
Trial: 154872
Drug: topical ethyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: topical ethyl lactate lotion only
Trial: 7488359
Drug: Colgate Winterfresh
RxNorm normalized name: Colgate
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Colgate Winterfresh Gel with 0.76% sodium monofluorophosphate (MFP)
Trial: 3328680
Drug: No calcium
RxNorm normalized name: DPBS 1X, NO CALCIUM, NO MAGNESIUM
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No calcium channel blocker (Group 3, n = 15)
Trial: 29525970
Drug: Stopping oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stopping oral bisphosphonate treatment (ibandronate, alendronate, risedronate)
Trial: 26073181
Drug: Pregabalin (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin (150 mg, dosed twice daily)
Trial: 26073181
Drug: Mirogabalin (17.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirogabalin (17.7 mg estimated dose)
Trial: 26073181
Drug: Mirogabalin (twice-daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirogabalin (twice-daily dosing)
Trial: 20622383
Drug: 1 mg/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg/day of Fungisome
Trial: 20622383
Drug: 3 mg/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg/kg/day of Fungisome
Trial: 17078006
Drug: Combination probiotics
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination probiotics and nutrients
Trial: 11369844
Drug: Early intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early intervention with epoetin beta (Hb level 11‐12.5 g/dl, target Hb 13‐15 g/dl)
Trial: 11369844
Drug: Late intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Late intervention with epoetin beta (Hb level <10.5 g/dl, target Hb 10.5‐11.5 g/dl)
Trial: 9416886
Drug: Sitostanol ester
RxNorm normalized name: disodium ascorbyl sitostanol phosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitostanol ester margarine (3 g/d) for 7 weeks
Trial: 8512911
Drug: Low level
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low level laser therapy (LLLT) applied to one side of the mouth after surgery
Trial: 2979215
Drug: Intravenous famotidine
RxNorm normalized name: Famotidine
DrugBank: Famotidine (DB00927)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous famotidine at 10 ng ml-1
Trial: 2979215
Drug: Intravenous famotidine
RxNorm normalized name: Famotidine
DrugBank: Famotidine (DB00927)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous famotidine at 30 ng ml-1
Trial: 2979215
Drug: Intravenous famotidine
RxNorm normalized name: Famotidine
DrugBank: Famotidine (DB00927)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous famotidine at 90 ng ml-1
Trial: 29565636
Drug: Usual Care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual Care + Homeopathy Treatment (UC + HT)
Trial: 26693800
Drug: DHAP (dexamethasone,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHAP (dexamethasone, high-dose cytarabine, cisplatin)
Trial: 24527578
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese Medicine treatment
Trial: 24527578
Drug: Regular Western
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular Western and Chinese medicine treatments
Trial: 11982446
Drug: Citalopram medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram medication
Trial: 11982446
Drug: Both treated
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Both treated groups (Citalopram and Cognitive-behavioral therapy)
Trial: 11982446
Drug: Responders (regardless
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Responders (regardless of treatment approach)
Trial: 8552510
Drug: Intravenous aspirin
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous aspirin (0.015 g/kg body weight)
Trial: 21779973
Drug: Psyllium (3.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psyllium (3.6 g × 2/day) during rehabilitation
Trial: 21779973
Drug: High-fiber diet
RxNorm normalized name: fiber
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-fiber diet (approximately 30 g fiber per day) during rehabilitation
Trial: 9758264
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (0.8 mg)‐containing multivitamin supplementation
Trial: 9758264
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (1 mg)‐containing multivitamin
Trial: 9758264
Drug: Physiological dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiological dose (<1 mg) of folic acid
Trial: 4359162
Drug: l(‐) amphetamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l(‐) amphetamine
Trial: 4359162
Drug: l(‐) amphetamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l(‐) amphetamine and d(+) amphetamine
Trial: 31943197
Drug: Amitriptyline (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (10 to 50 mg daily)
Trial: 24040767
Drug: Retransfusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Retransfusion of unwashed cardiotomy suction blood (mean volume 280 ml, corresponding to 5% of blood volume)
Trial: 19522261
Drug: Perioperative epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perioperative epidural buprenorphine 0.2 mg
Trial: 11765143
Drug: Capsule formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsule formulation (500 mg sitafloxacin)
Trial: 11765143
Drug: Intravenous formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous formulation (400 mg sitafloxacin)
Trial: 9267668
Drug: Paclitaxel 170
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 170 mg/m2 and Cyclophosphamide 2 gm/m2
Trial: 9267668
Drug: Paclitaxel 200
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 200 mg/m2 and Cyclophosphamide 3 gm/m2
Trial: 9267668
Drug: Prior chemotherapy
RxNorm normalized name: Priorix
DrugBank: Rubella virus vaccine (DB10317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prior chemotherapy regimen (1 vs more than 1)
Trial: 9267668
Drug: Prior radiation
RxNorm normalized name: Priorix
DrugBank: Rubella virus vaccine (DB10317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prior radiation therapy
Trial: 8488991
Drug: etomidate in
RxNorm normalized name: etomidate Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: etomidate in lipid emulsion formulation (Lipofundin MCT 20%; eto-lip)
Trial: 3449066
Drug: Ambroxol, 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ambroxol, 3 x 30 mg for 7 days
Trial: 3449066
Drug: Gelomyrtol forte,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gelomyrtol forte, 4 x 1 capsule (1 capsule = 0.3 g Myrtol, standardized to at least 20 mg of alpha-pinene, 75 mg of limonene, and 75 mg of cineole) for 7 days
Trial: 29475197
Drug: Perioperative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perioperative chemotherapy regimens
Trial: 23134522
Drug: Nifedipine GITS
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine GITS 30 mg plus valsartan 80 mg (N + V)
Trial: 23134522
Drug: High-dose valsartan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose valsartan (160 mg) monotherapy (V160)
Trial: 19026302
Drug: Atorvastatin 20
RxNorm normalized name: atorvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 20 mg plus ezetimibe 10 mg
Trial: 15808114
Drug: SIT with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SIT with modified Dermatophagoides pteronyssinus 100 % allergen vaccine (n = 25)
Trial: 15808114
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (pharmacological treatment only, n = 25)
Trial: 14506330
Drug: Rebamipide (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rebamipide (100 mg, 3 times/day for 7 days before surgery)
Trial: 9607389
Drug: Fosinopril (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fosinopril (10 to 20 mg daily orally)
Trial: 9607389
Drug: Atenolol (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (25 to 50 mg daily orally)
Trial: 2650581
Drug: Quinapril 20
RxNorm normalized name: quinapril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinapril 20 mg daily
Trial: 2650581
Drug: Quinapril 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinapril 80 mg daily
Trial: 22809664
Drug: Paracetamol (60/80/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol (60/80/100 mg based on birth weight)
Trial: 21336727
Drug: VitalStim therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VitalStim therapy plus conventional swallowing training
Trial: 21336727
Drug: VitalStim therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VitalStim therapy
Trial: 10654038
Drug: OGA L
RxNorm normalized name: L-377202
DrugBank: L-377202 (DB19022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OGA L film using Lanex Regular screens (Lanex group)
Trial: 9299800
Drug: Cognitive behavior
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavior therapy alone
Trial: 9299800
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of fluoxetine and cognitive behavior therapy
Trial: 8345004
Drug: Sodium valproate
RxNorm normalized name: sodium valproate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium valproate 3000 mg
Trial: 8345004
Drug: Sodium valproate
RxNorm normalized name: sodium valproate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium valproate 2000 mg
Trial: 8345004
Drug: Sodium valproate
RxNorm normalized name: sodium valproate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium valproate 1000 mg
Trial: 8345004
Drug: Total drug
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total drug concentration above 100 mg/l
Trial: 29248173
Drug: Trabeculectomy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trabeculectomy with mitomycin C (0.4 mg/ml for 2 minutes)
Trial: 29092079
Drug: Intranasal benzhydrocodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal benzhydrocodone API (13.34 mg)
Trial: 29092079
Drug: Intranasal hydrocodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal hydrocodone bitartrate API (15.0 mg)
Trial: 26365330
Drug: 15‐mg zinc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15‐mg zinc sulfate daily from the 16th week of gestation until delivery
Trial: 26365330
Drug: 15‐mg zinc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15‐mg zinc sulfate
Trial: 24210923
Drug: Gastrostomy tube
RxNorm normalized name: gastrostomy tube
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gastrostomy tube (G-tube) feeding
Trial: 24210923
Drug: Oral only
RxNorm normalized name: TABLET, ORAL ONLY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral only feeding
Trial: 22658359
Drug: Itraconazole in
RxNorm normalized name: itraconazole Injectable Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole in addition to DMARD therapy
Trial: 22658359
Drug: Standard DMARD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard DMARD therapy plus placebo
Trial: 18681789
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg clomiphene citrate plus placebo (n = 209)
Trial: 18681789
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g extended-release metformin plus placebo (n = 208)
Trial: 18681789
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of metformin and clomiphene (n = 209)
Trial: 18681789
Drug: Metformin XR
RxNorm normalized name: metformin Extended Release Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin XR (2 g/day)
Trial: 8934149
Drug: Placebo (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0 mg nicotine gum)
Trial: 25275724
Drug: MVA E2
RxNorm normalized name: MVA
DrugBank: Modified vaccinia ankara (DB15483)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MVA E2 therapeutic vaccine (10^7 virus particles injected directly into uterus, urethra, vulva, or anus)
Trial: 19363022
Drug: Dexamethasone (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (100 mg intramuscular injections at baseline and 6 weeks)
Trial: 11927515
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogens (CEEs) 0.625 mg
Trial: 11927515
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of CEEs and simvastatin
Trial: 7500130
Drug: Daily 2‐h
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily 2‐h manual practice sessions for 5 days
Trial: 7500130
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group 1: Daily TMS mapping without piano practice
Trial: 2613427
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (very low calorie diet + behavior therapy)
Trial: 773495
Drug: Dipyridamole and
RxNorm normalized name: Dipyridamole
DrugBank: Dipyridamole (DB00975)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dipyridamole and aspirin (given by mouth from the evening before operation and for seven days after operation)
Trial: 31842127
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid treatment
Trial: 31842127
Drug: Non-acetylsalicylic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-acetylsalicylic acid treatment
Trial: 26769332
Drug: INCB039110 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: INCB039110 100 mg once daily
Trial: 26769332
Drug: INCB039110 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: INCB039110 200 mg once daily
Trial: 26769332
Drug: INCB039110 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: INCB039110 200 mg twice daily
Trial: 26769332
Drug: INCB039110 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: INCB039110 600 mg once daily
Trial: 25171502
Drug: Tamsulosin 0.4
RxNorm normalized name: tamsulosin 0.4 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.4 mg (TAM) + Solifenacin 5 mg (SOL)
Trial: 25171502
Drug: Tamsulosin 0.4
RxNorm normalized name: tamsulosin 0.4 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.4 mg (TAM)
Trial: 17618427
Drug: Tolfenamic acid
RxNorm normalized name: Tolfenamic acid
DrugBank: Tolfenamic acid (DB09216)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolfenamic acid 200 mg t.i.d. for 3 days
Trial: 15908834
Drug: Methylphenidate transdermal
RxNorm normalized name: methylphenidate Transdermal System
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate transdermal system (MTS) at doses of 0.45 mg/h, 0.9 mg/h, and 1.8 mg/h
Trial: 10469092
Drug: Liposome-encapsulated caffeine-based
RxNorm normalized name: caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liposome-encapsulated caffeine-based cream (higher concentration)
Trial: 10469092
Drug: Liposome-encapsulated caffeine-based
RxNorm normalized name: caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liposome-encapsulated caffeine-based cream (lower concentration)
Trial: 2153719
Drug: Topical nedocromil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical nedocromil sodium
Trial: 7018644
Drug: Hydroxyzine 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyzine 0.5 mg/kg (n = 43)
Trial: 7018644
Drug: Promethazine 0.5
RxNorm normalized name: PROMETHAZINE 0.5MG/ML/NACL INJ BAG 50ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Promethazine 0.5 mg/kg (n = 40)
Trial: 7018644
Drug: Diazepam 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 0.1 mg/kg (n = 378)
Trial: 31727664
Drug: Rotarix (third
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rotarix (third dose)
Trial: 22429586
Drug: Adalimumab 40
RxNorm normalized name: ADALIMUMAB 40MG/0.8ML INJ,PEN,KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adalimumab 40 mg every other week (eow) as continuous treatment
Trial: 22429586
Drug: Adalimumab 40
RxNorm normalized name: ADALIMUMAB 40MG/0.8ML INJ,PEN,KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adalimumab 40 mg every other week (eow) after retreatment
Trial: 22429586
Drug: Adalimumab continuous
RxNorm normalized name: Adalimumab
DrugBank: Adalimumab (DB00051)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Adalimumab continuous treatment
Trial: 22016976
Drug: Method for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Method for calming the liver and suppressing Yang (Traditional Chinese Medicine)
Trial: 22016976
Drug: Thiamazole tablets
RxNorm normalized name: thiamazole
DrugBank: Methimazole (DB00763)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thiamazole tablets
Trial: 9177609
Drug: UVB treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UVB treatment (15 patients)
Trial: 9177609
Drug: PUVA treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PUVA treatment (11 patients)
Trial: 22722512
Drug: MK-0657 monotherapy
RxNorm normalized name: vitamin MK 7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-0657 monotherapy (4-8 mg/d)
Trial: 12113286
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 600 mg per day
Trial: 10892417
Drug: Oxytocin antagonists
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin antagonists
Trial: 8750221
Drug: Intraperitoneal (IP)
RxNorm normalized name: Intraperitoneal Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraperitoneal (IP) insulin infusion at 2 mU/kg‐1 min‐1
Trial: 8750221
Drug: Intravenous (IV)
RxNorm normalized name: intravenous (IV) infusion pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (IV) insulin infusion at 1 mU/kg‐1 min‐1
Trial: 6358126
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose nimodipine therapy